PDT Partners’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,343
Closed -$188K 628
2025
Q3
$188K Sell
13,343
-816
-6% -$12.7K 0.01% 549
2025
Q2
$272K Buy
+14,159
New +$221K 0.02% 609
2024
Q3
Sell
-9,630
Closed -$556K 796
2024
Q2
$556K Sell
9,630
-928
-9% -$45.5K 0.05% 442
2024
Q1
$352K Sell
10,558
-953
-8% -$48.3K 0.03% 509
2023
Q4
$934K Buy
11,511
+5,707
+98% +$464K 0.1% 298
2023
Q3
$947K Buy
+5,804
New +$1.37M 0.12% 298
2022
Q4
Sell
-1,634
Closed -$390K 817
2022
Q3
$390K Sell
1,634
-2,685
-62% -$719K 0.06% 507
2022
Q2
$963K Buy
4,319
+1,373
+47% +$591K 0.08% 403
2022
Q1
$2.01M Sell
2,946
-994
-25% -$598K 0.17% 176
2021
Q4
$2.72M Buy
3,940
+92
+2% +$68K 0.21% 174
2021
Q3
$2.85M Buy
+3,848
New +$2.62M 0.21% 203

Other funds holding OM

PDT Partners's OM Position: Q4 2025 in Review

PDT Partners sold out of Outset Medical (OM) in Q4 2025, closing a stake of 13,343 shares — an estimated $188K sold.

PDT Partners first reported a position in OM in Q3 2021 and held it in 11 quarters. The position peaked at $2.85M in Q3 2021. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • PDT Partners reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • PDT Partners sold 13,343 Outset Medical shares in Q4 2025, an estimated $188K.
  • PDT Partners first reported a position in Outset Medical in Q3 2021 and held it in 11 quarters.
  • PDT Partners's Outset Medical position peaked at $2.85M in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on PDT Partners's 13F filing for Q4 2025, filed 17 Feb 2026.